XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Total
Balance at Dec. 31, 2020   $ 7,250 $ (77,541) $ 83,183 $ 339,917 $ (1,910) $ 350,899
Increase (decrease) in shareholders' equity              
Net Income (Loss) Attributable to the Company         4,061   4,061
Vested Restricted Stock and Performance Shares       (436)     (436)
Exercise of Stock Options and Stock Issuance to Directors       372     372
Equity Issuance Costs       (428)     (428)
Stock-Based Compensation Expense       1,336     1,336
Par Value $0.01 per Share and Treasury Stock Derecognized at January 29, 2021   (7,190) 77,541 (70,351)      
Common Stock Dividends Declared for the Period         (12,083)   (12,083)
Other Comprehensive Income           1,170 1,170
Balance at Jun. 30, 2021   60   13,676 331,895 (740) 344,891
Balance at Dec. 31, 2020   7,250 $ (77,541) 83,183 339,917 (1,910) 350,899
Balance at Dec. 31, 2021 $ 30 60   85,414 343,459 1,517 430,480
Balance at Mar. 31, 2021   60   13,341 341,645 (673) 354,373
Increase (decrease) in shareholders' equity              
Net Income (Loss) Attributable to the Company         (3,724)   (3,724)
Exercise of Stock Options and Stock Issuance to Directors       80     80
Equity Issuance Costs       (412)     (412)
Stock-Based Compensation Expense       667     667
Common Stock Dividends Declared for the Period         (6,026)   (6,026)
Other Comprehensive Income           (67) (67)
Balance at Jun. 30, 2021   60   13,676 331,895 (740) 344,891
Balance at Dec. 31, 2021 30 60   85,414 343,459 1,517 430,480
Increase (decrease) in shareholders' equity              
Net Income (Loss) Attributable to the Company         1,420   1,420
Adjustment to Equity Component of Convertible Debt Upon Adoption of ASU 2020-06       (7,034) 4,022   (3,012)
Stock Repurchase       (1,147)     (1,147)
Vested Restricted Stock and Performance Shares       (845)     (845)
Exercise of Stock Options and Stock Issuance to Directors       237     237
Stock Issuance, Net of Equity Issuance Costs   1   8,478     8,479
Stock-Based Compensation Expense       1,244     1,244
Preferred Stock Dividends Declared for the Period         (2,391)   (2,391)
Common Stock Dividends Declared for the Period         (13,594)   (13,594)
Other Comprehensive Income           10,623 10,623
Balance at Jun. 30, 2022 30 61   86,347 332,916 12,140 431,494
Balance at Mar. 31, 2022 30 60   81,092 339,828 9,529 430,539
Increase (decrease) in shareholders' equity              
Net Income (Loss) Attributable to the Company         1,218   1,218
Stock Repurchase       (1,147)     (1,147)
Exercise of Stock Options and Stock Issuance to Directors       88     88
Stock Issuance, Net of Equity Issuance Costs   1   5,689     5,690
Stock-Based Compensation Expense       625     625
Preferred Stock Dividends Declared for the Period         (1,196)   (1,196)
Common Stock Dividends Declared for the Period         (6,934)   (6,934)
Other Comprehensive Income           2,611 2,611
Balance at Jun. 30, 2022 $ 30 $ 61   $ 86,347 $ 332,916 $ 12,140 $ 431,494